Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 4,561 - 4,580 results of 106,627 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.71s Refine Results
  1. 4561
    Overexpression of Mov10 decreases HIV-1 infectivity.

    Overexpression of Mov10 decreases HIV-1 infectivity. by Vyacheslav Furtak (253807)

    Published 2010
    Save to List
    Saved in:
  2. 4562
    Retinoschisin secretion into the conditioned medium is decreased by addition of taxol.

    Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

    Published 2013
    “…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”
    Save to List
    Saved in:
  3. 4563
    Rapamycin acts in the brain to decrease body weight gain.

    Rapamycin acts in the brain to decrease body weight gain. by Mark Hebert (558822)

    Published 2014
    “…<p>A and B: RAP i.c.v. injection (Day 0, broken line) induces a transient decrease in body weight gain (A), which results in prolonged shift in body weight (B). …”
    Save to List
    Saved in:
  4. 4564
    Image_5_Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.JPEG

    Image_5_Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.JPEG by Deepti P. Karumathil (5258156)

    Published 2018
    Save to List
    Saved in:
  5. 4565
    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  6. 4566
    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  7. 4567
    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  8. 4568
    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  9. 4569
    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  10. 4570
    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  11. 4571
    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx

    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  12. 4572
    SP1049C treatment decreases tumor aggressiveness.

    SP1049C treatment decreases tumor aggressiveness. by Daria Y. Alakhova (447558)

    Published 2013
    Save to List
    Saved in:
  13. 4573
    Descriptive analysis of antibodies concentrations by Elecsys Anti-SARS-CoV-2 S and EliA SARS-CoV-2-Sp1 IgG in the 256 non-infected volunteers included in the study.

    Descriptive analysis of antibodies concentrations by Elecsys Anti-SARS-CoV-2 S and EliA SARS-CoV-2-Sp1 IgG in the 256 non-infected volunteers included in the study. by Antonio Fernández-Suárez (14053814)

    Published 2022
    Save to List
    Saved in:
  14. 4574
    Effect of gadolinium on strain-induced decrease in DNA counts.

    Effect of gadolinium on strain-induced decrease in DNA counts. by Hui Yin Nam (4175437)

    Published 2017
    “…(B) In the presence of Gd<sup>3+</sup>, 8% + 1 Hz for 72 h significantly decreased DNA count. The result was expressed as a mean ± 1 SD for five randomly selected fields in 3 independent experiments. …”
    Save to List
    Saved in:
  15. 4575
    Excitotoxicity-induced decrease in GAD65/67 activity.

    Excitotoxicity-induced decrease in GAD65/67 activity. by Márcio S. Baptista (365618)

    Published 2013
    Save to List
    Saved in:
  16. 4576
    Decreased UFA/SFA ratio induces cytosolic chaperones.

    Decreased UFA/SFA ratio induces cytosolic chaperones. by Dongyeop Lee (108880)

    Published 2019
    Save to List
    Saved in:
  17. 4577
    Que decreases the number of infiltrating T cells in spinal cord.

    Que decreases the number of infiltrating T cells in spinal cord. by Feng Mei (143817)

    Published 2012
    “…<b>E–G</b>: CD8<sup>+</sup> cells display a similar decrease after Que treatment (N = 5, *, <i>p<</i>0.05), but the overall extent of CD8<sup>+</sup> cells detected was much less than that of CD4<sup>+</sup> cells. …”
    Save to List
    Saved in:
  18. 4578
    OIP5-AS1 modulates cell apoptosis via miR-145-5p.

    OIP5-AS1 modulates cell apoptosis via miR-145-5p. by Jingyan Yang (7120994)

    Published 2025
    Save to List
    Saved in:
  19. 4579
    SARS-CoV-2 infected Tryptophan hydroxylase 2 (TPH2)-positive cells in the ventral tegmental area.

    SARS-CoV-2 infected Tryptophan hydroxylase 2 (TPH2)-positive cells in the ventral tegmental area. by Motoki Imai (7324697)

    Published 2024
    Save to List
    Saved in:
  20. 4580
    SARS-CoV-2 infected Tryptophan hydroxylase 2 (TPH2)-positive cells in the ventral tegmental area.

    SARS-CoV-2 infected Tryptophan hydroxylase 2 (TPH2)-positive cells in the ventral tegmental area. by Motoki Imai (7324697)

    Published 2024
    Save to List
    Saved in:

Search Tools: